Towards a dynamical network view of brain ischemia and reperfusion. Part III: Therapeutic implications

Journal of Experimental Stroke and Translational Medicine

Volumn 3, Issue 1, 2010, Pages 90-103

  DeGracia, Donald J ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Allometry; Bistability; Global brain ischemia and reperfusion; Neuroprotection; Post ischemic state space

Indexed keywords

EID: 77953079993     PISSN: 1939067X     EISSN: 1939067X     Source Type: Journal    
DOI: 10.6030/1939-067X-3.1.90     Document Type: Article

References (42)

1. Brown JH, West GB, Enquist BJ. (2000) Scaling in biology: patterns and processes, causes and consequences. In: Scaling in Biology (Santa Fe Institute Studies in the Sciences of Complexity Proceedings). Brown JH and West GB (ed). Oxford University Press, New York. pp 1-24
2. Chao MV. (1992) Growth factor signaling: Where is the specificity? Cell 68:995-997
3. Chiba T, Ikawa Y, Todokoro K. (1991) GATA-1 transactivates erythropoietin receptor gene, and erythropoietin receptor-mediated signals enhance GATA-1 gene expression. Nucleic Acids Res 19:3843-3848 (Pubitemid 21912750)
4. Corbett D, Nurse S. (1998) The problem of assessing effective neuroprotection in experimental cerebral ischemia. Prog Neurobiol. 54:531-548 (Pubitemid 28123325)
5. Cornish-Bowden A, Cárdenas ML, Letelier JC, Soto-Andrade J. (2007) Beyond reductionism: metabolic circularity as a guiding vision for a real biology of systems. Proteomics 7:839-845 (Pubitemid 46506731)
6. Curry SH. (2003) Why Have So Many Drugs with Stellar Results in Laboratory Stroke Models Failed in Clinical Trials? Annals of the New York Academy of Sciences 993:69-74
7. Dani DN, Sainis JK. (2007) Modularity: a new perspective in biology. Indian J Biochem Biophys 44:133-139
8. de la Fuente A, Mendes P. (2003) Integrative modeling of gene expression and cell metabolism. Appl Bioinformatics 2:79-90
9. DeGracia DJ. (2008) Ischemic damage and neuronal stress responses: Towards a systematic approach with implications for therapeutic treatments. In New Frontiers in Neurological Research. Wang DQ and Ying W (eds). Research Signpost,Kerala, India. pp 235-264
10. Dirnagl U. (2006) Bench to bedside: the quest for quality in experimental stroke research. J Cereb Blood Flow Metab 26:1465-1478
11. Donnan GA. (2008) The 2007 Feinberg Lecture: A New Road Map for Neuroprotection. Stroke 39;242-248
12. Dronne MA, Grenier E, Dumont T, Hommel M, Boissel JP. (2007) Role of astrocytes in grey matter during stroke: a modeling approach. Brain Res 1138:231-242
13. Enver T, Heyworth CM, Dexter TM. (1998) Do stem cells play dice? Blood 92:348-351
14. Fisher M, Feuerstein G, Howells DW, Hurn PD, Kent TA, Savitz SI, Lo EH. (2009) Update of the stroke therapy academic industry roundtable preclinical recommendations. Stroke 40:2244-2250
15. Flynn RW, MacWalter RS, Doney AS. (2008) The cost of cerebral ischaemia. Neuropharmacology 55:250-256
16. Fukuda S, Warner DS. (2007) Cerebral protection. Br J Anaesth 99:10-17
17. Ginsberg MD. (2008) Neuroprotection for ischemic stroke: past, present and future. Neuropharmacology 55:363-389
18. Huang S, Eichler G, Bar-Yam Y, Ingber DE. (2005) Cell fates as high-dimensional attractor states of a complex gene regulatory network. Phys Rev Lett 94:128701-1-128701-128704
19. Huang S, Ingber DE. (2000) Shape-dependent control of cell growth, differentiation, and apoptosis: switching between attractors in cell regulatory networks. Exp Cell Res 261:91-103
20. Ilsley GR, Luscombe NM, Apweiler R. (2009) Know your limits: assumptions, constraints and interpretation in systems biology. Biochim Biophys Acta 1794:1280-1287
21. Kroemer G, Galluzzi L, Vandenabeele P, Abrams J, Alnemri ES, Baehrecke EH, Blagosklonny MV, El-Deiry WS, Golstein P, Green DR, Hengartner M, Knight RA, Kumar S, Lipton SA, Malorni W, Nuñez G, Peter ME, Tschopp J, Yuan J, Piacentini M, Zhivotovsky B, Melino G; Nomenclature Committee on Cell Death 2009. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009. Cell Death Differ 16:3-11
22. Kumar R, Krause GS, Yoshida H, Mori K, DeGracia DJ. (2003) Dysfunction of the Unfolded Protein Response During Global Brain Ischemia and Reperfusion. J Cereb Blood Flow Metab 23:462-471 (Pubitemid 36403028)
23. Kuroiwa T, Okeda R. (2003) Checkpoints and pitfalls in the experimental neuropathology of circulatory disturbance. Neuropathology 23:79-89 (Pubitemid 36406792)
24. Lindquist S. (1986) The heat-shock response. Annu Rev Biochem 55:1151-1191
25. Lipton P. (1999) Ischemic cell death in brain neurons. Physiol Rev 79:1431-1568
26. Macarthur BD, Ma'ayan A, Lemischka IR. (2009) Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol 10:672-681
27. MacManus JP, Buchan AM. (2000) Apoptosis after experimental stroke: fact or fashion? J Neurotrauma 17:899-914
28. Martin LJ, Al-Abdulla NA, Brambrink AM, Kirsch JR, Sieber FE, Portera-Cailliau C. (1998) Neurodegeneration in excitotoxicity, global cerebral ischemia, and target deprivation: A perspective on the contributions of apoptosis and necrosis. Brain Res Bull 46:281-309
29. Molina CA, Alvarez-Sabín J. (2009) Recanalization and reperfusion therapies for acute ischemic stroke. Cerebrovasc Dis 27(Suppl 1):162-167
30. Nicotera P, Leist M, Manzo L. (1999) Neuronal cell death: a demise with different shapes. Trends Pharmacol Sci 20:46-51 (Pubitemid 29322309)
31. O'Callaghan PM, James DC. (2008) Systems biotechnology of mammalian cell factories. Brief Funct Genomic Proteomic 7:95-110 (Pubitemid 351728951)
32. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW. 1,026 experimental treatments in acute stroke. Ann Neurol 2006 59:467-477
33. Petito CK, Torres-Munoz J, Roberts B, Olarte JP, Nowak TS Jr, Pulsinelli WA. (1997) DNA fragmentation follows delayed neuronal death in CA1 neurons exposed to transient global ischemia in the rat. J Cereb Blood Flow Metab; 17:967-976 (Pubitemid 27396585)
34. Portera-Cailliau C, Price DL, Martin LJ. Non-NMDA and NMDA receptor-mediated excitotoxic neuronal deaths in adult brain are morphologically distinct: further evidence for an apoptosis-necrosis continuum. J Comp Neurol 1997 378:88-104
35. Rodgers JL, Nicewander WA, Toothaker L. (1984) Linearly Independent, Orthogonal, and Uncorrelated Variables. The American Statistician 38:133-134
36. Röther J. (2008) Neuroprotection Does Not Work! Stroke 39;523-524
37. Santos NC, Figueira-Coelho J, Martins-Silva J, Saldanha C. (2003) Multidisciplinary utilization of dimethyl sulfoxide: pharmacological, cellular, and molecular aspects. Biochem Pharmacol 65:1035-1041
38. Siesjö BK, Smith ML. (1991) The biochemical basis of ischemic brain lesions. Arzneimittelforschung 41:288-292
39. Sun L, Kuroiwa T, Ishibashi S, Miki K, Li S, Xu H, Endo S, Mizusawa H. (2009) Two region-dependent pathways of eosinophilic neuronal death after transient cerebral ischemia. Neuropathology 29:45-54
40. Tanouchi Y, Pai A, You L. (2009) Decoding biological principles using gene circuits. Mol Biosyst 5:695-703
41. Weigl M, Tenze G, Steinlechner B, Skhirtladze K, Reining G, Bernardo M, Pedicelli E, Dworschak M. (2005) A systematic review of currently available pharmacological neuroprotective agents as a sole intervention before anticipated or induced cardiac arrest. Resuscitation 65:21-39
42. Yakovlev AG, Faden AI. (2004) Mechanisms of neural cell death: implications for development of neuroprotective treatment strategies. NeuroRx 1:5-16